Introduction
Globally, the pandemic of HIV and AIDS has continued to constitute serious public health and socio economic challenges for more than two decades (1) . Today, about 33.3 million persons were estimated to be infected with HIV (1, 2) . Of these, 22.5 million (68%) were in Sub-Saharan Africa and about 3.0 million in Nigeria (3) . This therefore makes Nigeria the second highest after South Africa with number of people living with HIV in the world (2, 4, 7) . The national declines in HIV incidence in populations shows that sustained investigations and increased political leadership for the AIDS response are paying. In the last ten (10) years, the landscape of national HIV epidemics has changed dramatically for the better in most countries especially in Sub-Saharan Africa with fewer new HIV infections across the world in 2011 than 2001 (3,) . In Plateau State, there was a continues decline in HIV prevalence rates from 11.3% to 3.35% from 2001 to 2008 recorded and then a sharp rise to 7.7% in 2010 (4) . HIV/AIDS remains one of the major challenges to public health in the world today (5, 6) . Establishing the burden of the infection and the risk factors that contribute to its spread is a key to finding and instituting appropriate intervention strategies to curtail the spread of the disease (5) . Hepatitis B is a major disease of serious global public health proportion; It is preventable with safe and effective vaccines that have been available since 1982 (8, 9) . Of the 2 billion people who have been infected with the hepatitis B virus (HBV) globally, more than 350 million have chronic (lifelong) infections. Over 20 million people are infected annually with this virus (10 -12) . Hepatitis C is a viral infection of the liver and is the most common blood-borne (direct contact with human blood) infection (11, 13) . The major causes of HCV infection worldwide are use of unscreened blood transfusions, and re-use of needles and syringes that have not been adequately sterilized (14) . The world health organization (WHO) estimates that about 3% of the world populations (200 million people) have so far been infected with the Hepatitis C virus. Almost 50% of all cases become chronic carriers and are at risk of liver cirrhosis and liver cancer (10,12,) . HIV and Viral Hepatitis B/C are major public health concern and because of shared routes of transmissions, HIV/HCV coinfection and HIV/HBV coinfection or both are common (6,8,11,) . Viral Hepatitis B/C virus infections with a prevalence of 15.1% and 6.0% respectively are endemic in Nigeria and could lead to chronic liver disease, cirrhosis and cancer with high mortality and morbidity rates (7, 9, 14) .
Knowledge, Attitudes, and Behaviors about HIV and Viral Hepatitis.
AIDS cases are becoming visible in Nigeria with at least one out of every four persons had seen someone with HIV or known someone who die of AIDS (7,13,) . However, mortality and morbidity rates of viral hepatitis B and C infections are on the increase with high prevalence of 15.1% and 6.0% (14) . Awareness of HIV/AIDS was generally very high (93.8%) while viral hepatitis still remains silent. However, correct knowledge of all the routes of HIV, Hepatitis B virus and Hepatitis C virus infections transmissions and two methods of preventions haves remain (11, 13, 16) .
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Material and Method
The study population considered was of age ranging from 5 -79 years old of Mabudi rural community of Plateau State, Nigeria. After counseling and obtaining consent from 250 participants, they were then recruited and screened for HIV, HBsAg and Anti-HCV. WHO/CDC national algorithm of serial testing was employed for HIV antibody using Determine, Uni-Gold, and Stat-Pak. HBsAg and Anti-HCV was also determined using rapid test kits from Micropoint Bioscience Inc. Santa Clara, Califonia.
Laboratory Screening
HIV, HBsAg and Anti-HCV testing was conducted only by qualified Laboratory Scientists as blood specimens were collected from the participants into EDTA tubes in step by step serial algorithm for HIV. Nonreactive specimens were reported as NEGATIVE. Reactive specimens were confirmed with Uni-Gold HIV test kit. While reactive with both Determine and Uni-Gold were reported as POSITIVE. However, the same blood specimens were screened for viral hepatitis B and C respectively using a one-step rapid test kits (Micropoint) and results recorded.
Results
Out of the 250 participants, 6 (2.4%) were positive for HIV; 55 (22.0%) for HBsAg and 31 (12.4%) for Anti-HCV respectively. Coinfection rates of HIV/HBsAg/Anti-HCV was 1 (0.4%); HIV/HBsAg was 2 (0.8%) and HBsAg/Anti-HCV was 6 (2.4%), both sexes were equally affected with prevalence of 1.2% each; While for HBsAg the males showed higher prevalence of 34 (13.6%) than the females 21 (8.4%). However, the prevalence of Anti-HCV was higher in the females with 18 (7.2%) than in the males with 13 (5.2%). The highest prevalence rates of HIV, HBsAg and Anti-HCV were observed in the age group of 20 -30 (2.0%); 10 -39 (17.6%) and 30 -59 (8.4%) respectively. Significant P. values of 0.07, 0.9 and 0.02 for HIV, HBsAg and Anti-HCV with confident interval of 95% were observed in this study. 
Discussion
From this study, the Langtang South HIV prevalence rate has dropped drastically from 9.7% reported in 2008 to 2.4% which is lower than the National HIV prevalence of 2.7% reported for rural setting in North Central zone of Nigeria. 22% prevalence of HBV infection reported in this study was higher than the 10.3%, 12.5% reported in Jos and Benin by Sirisena ND (2002) and Ugbebor (2011). However, this supported the WHO's report for Nigeria as highly endemic area with prevalence greater than 8% for HBV. The prevalence of 12.4% for Anti-HCV in this study was found to be higher when compared with the study in Jos and Benin with 5.2% and 3.6%. In this, coinfection rates 0.4% for HIV/HBsAg and Anti-HCV was found to be lower than the 11.9%, 4.8% and 1% reported in Ibadan by Otegbayo (2008) while in Iran, a prevalence of 14.5%, 72% and 7.9% was recorded by Mohsen (2009) . For HIV, both sexes were equally affected with a prevalence of 1.2% each while for HBsAg the males showed higher prevalence of 13.6% than females 8.4%; however, Anti-HCV was higher in females with 7.2% than in males with 5.2% recorded in our study which is found to be lower than the coinfection rates of 21.2% in women and 6.7% in males respectively reported by Mohsen (2009) in Iran. In our study, a lower prevalence rate of HIV, HBsAg and Anti-HCV were observed among age group of 20-39 (2.0%), 10-39 (17.6%) and 30-59 (8.4%) as compared to the one in Iran 77.2% for less than 30 years and 74.2% in patients between 31-50 age ranges. Awareness of HIV/AIDS was generally very high (93.8%) while viral hepatitis still remains silent (Nigeria GARPR 2012). However, correct knowledge of all the routes of HIV, Hepatitis B virus and Hepatitis C virus infections, transmissions and two methods of preventions have remained as compared to our study, 85.2% have heard of at least one of the viral diseases. 47% have been tested of either HIV or viral Hepatitis B/C. Alcoholism is responsible for 4,700 deaths per year among young people under the age of 21 -29. David Jermigan (2013) reported that more than 70% high school students have consumed alcohol, and about 22% engage in heavy episode drinking as compared to our study found that 26% drink alcohol this cut across every age group (i.e. 18 -49 years).
Conclusion
From this study, the Langtang South HIV prevalence rate has dropped drastically from 9.7% reported in 2008 to 2.4% which is lower than the National HIV prevalence rate reported for rural settings in North Central Nigeria. This may be attributed to the scaling of the numerous interventions, policies, actions towards universal access to HIV prevention, treatment, care and support. However, the high rates of Hepatitis B and C viruses may warrant focusing on adequate care and treatment of infected individuals.
Recommendation
Further studies are needed so as to confirm these findings in HIV, Viral Hepatitis B, and C endemic areas. Diagnosis in HIV / HBsAg / Anti-HCV is vital in order to take care of the high rates of Hepatitis B and C virus may warrant focusing on adequate care and treatment of infected chronic individuals; however, there is a very high demand for hospital laboratory upgrade in the aspect of public health planning and development in Langtang South community of Plateau state Nigeria.
Future scope:
The findings from this study will be used for advocacy to policy makers to improve public health planning, resource mobilization and programme implementation.
